Status:
COMPLETED
Study of the Role of Innate Lymphoid Cells and Natural Killer Cells in Immune Activation of Vitiligo - INNATE Vitiligo
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Vitiligo
Eligibility:
All Genders
18+ years
Brief Summary
The cohort included only major patients with non-segmental vitiligo and no other autoimmune or inflammatory associated diseases (except thyroiditis). Control subjects should have no autoimmune or infl...
Detailed Description
The investigators want study the presence and type of ILC and NK in the blood and skin of vitiligo patients compared to control subjects.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- vitiligo subjects :
- patients in the cohort with non-segmental vitiligo
- without other autoimmune or inflammatory diseases associated
- control subjects :
- subject without autoimmune or inflammatory disease
Exclusion
Key Trial Info
Start Date :
July 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03859518
Start Date
July 1 2016
End Date
December 1 2019
Last Update
December 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CH de Frejus
Fréjus, France